Bladder Cancer: Narrowing the Gap Between Evidence and Practice

This publication has 64 references indexed in Scilit:

• Neoadjuvant chemotherapy for the treatment of muscle-invasive bladder cancer: argument in favor
  Nature Reviews Endocrinology, 2008
• A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery
  Proceedings of the National Academy of Sciences, 2007
• The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients With T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical Trial
  Journal of Urology, 2006
• Multicentric Study Comparing Intravesical Chemotherapy Alone and With Local Microwave Hyperthermia for Prophylaxis of Recurrence of Superficial Transitional Cell Carcinoma
  Journal of Clinical Oncology, 2003
• Neoadjuvant Cisplatinum Based Combination Chemotherapy in Patients with Invasive Bladder Cancer: A Combined Analysis of Two Nordic Studies
  European Urology, 2003
• Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
  New England Journal of Medicine, 2003
• The Value of a Second Transurethral Resection in Evaluating Patients with Bladder Tumours
  European Urology, 2003
• Perioperative Single Dose Instillation of Epirubicin or Interferon-α After Transurethral Resection for The Prophylaxis of Primary Superficial Bladder Cancer Recurrence: A Prospective Randomized Multicenter Study—Finnbladder III Long-Term Results
  Journal of Urology, 2002
• Phase I Trial of Intravesical Gemcitabine in Bacillus Calmette-Guérin–Refractory Transitional-Cell Carcinoma of the Bladder
  Journal of Clinical Oncology, 2002
• EFFICACY AND SAFETY OF VALRUBICIN FOR THE TREATMENT OF BACILLUS CALMETTE-GUERIN REFRACTORY CARCINOMA IN SITU OF THE BLADDER
  Journal of Urology, 2000